Page 4 - Nasdaq Kzia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq kzia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Kzia Today - Breaking & Trending Today

Reviewing Kazia Therapeutics (NASDAQ:KZIA) and Arcutis Biotherapeutics (NASDAQ:ARQT)

Kazia Therapeutics (NASDAQ:KZIA – Get Rating) and Arcutis Biotherapeutics (NASDAQ:ARQT – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Kazia Therapeutics and Arcutis Biotherapeutics’ […] ....

United States , New South Wales , Westlake Village , Arcutis Biotherapeutic , Arcutis Biotherapeutics , Arcutis Biotherapeutics Company Profile Get Rating , Arcutis Inc , Kazia Therapeutics Company Profile Get Rating , Kazia Therapeutics , Arcutis Biotherapeutics Inc , Get Rating , Given Kazia Therapeutic , Therapeutics Company Profile , Therapeutics Limited , Novogen Limited , Kazia Therapeutics Limited , Nasdaq Kzia , Stock Comparison , Stock Analysis ,

Kazia Therapeutics (NASDAQ:KZIA) Lifted to "Hold" at Zacks Investment Research

Kazia Therapeutics (NASDAQ:KZIA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company’s […] ....

New South Wales , Morgan Stanley , Zacks Investment Research , Envestnet Asset Management Inc , Citadel Advisors , Kazia Therapeutics , Susquehanna International Group , Get Rating , Therapeutics Limited , Novogen Limited , Asset Management , International Group , Nasdaq Kzia ,

Kazia Therapeutics (NASDAQ:KZIA) Upgraded to "Hold" by Zacks Investment Research

Kazia Therapeutics (NASDAQ:KZIA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Saturday, Zacks.com reports. According to Zacks, “Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The […] ....

New South Wales , Morgan Stanley , Zacks Investment Research , Envestnet Asset Management Inc , Citadel Advisors , Kazia Therapeutics , Susquehanna International Group , Get Rating , Therapeutics Limited , Novogen Limited , Asset Management , International Group , Nasdaq Kzia ,

Kazia Therapeutics (NASDAQ:KZIA) Raised to Hold at Zacks Investment Research

Kazia Therapeutics (NASDAQ:KZIA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Saturday, Zacks.com reports. According to Zacks, “Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company’s […] ....

New South Wales , Morgan Stanley , Zacks Investment Research , Envestnet Asset Management Inc , Citadel Advisors , Kazia Therapeutics Company Profile Get Rating , Kazia Therapeutics , Susquehanna International Group , Get Rating , Therapeutics Limited , Novogen Limited , Asset Management , International Group , Therapeutics Company Profile , Nasdaq Kzia ,

Kazia Therapeutics (NASDAQ:KZIA) Upgraded at Zacks Investment Research

Kazia Therapeutics (NASDAQ:KZIA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. […] ....

New South Wales , Morgan Stanley , Zacks Investment Research , Envestnet Asset Management Inc , Citadel Advisors , Kazia Therapeutics Company Profile Get Rating , Kazia Therapeutics , Susquehanna International Group , Get Rating , Therapeutics Limited , Novogen Limited , Asset Management , International Group , Therapeutics Company Profile , Nasdaq Kzia ,